Nordson Corporation (NDSN) reported a strong second quarter for fiscal 2026, achieving record sales of $741 million, an 8% increase year-over-year, driven by robust organic growth of 7%. The company’s backlog surged 18% organically, reflecting broad-based order momentum across all segments. Notably, adjusted earnings per share rose to $2.86, surpassing guidance and representing an 18% increase compared to the previous year. The company also highlighted a solid free cash flow of $170 million, maintaining a conversion rate of 119% on net income.
This performance underscores Nordson’s operational strength and strategic positioning in growth markets such as semiconductor and medical sectors. The acquisition of CapstanAG is expected to enhance the Precision Agriculture portfolio, contributing an estimated $5 million to $6 million in incremental sales in the second half of the year. With a leverage ratio now below its long-term target range, Nordson is well-positioned for future investments and shareholder returns.
Market professionals should note Nordson’s improved full-year guidance, with projected sales between $2.93 billion and $3.01 billion and adjusted EPS of $11.30 to $11.80, indicating continued confidence in its growth trajectory.
Source: fool.com